{"id":407273,"date":"2021-01-04T07:03:33","date_gmt":"2021-01-04T12:03:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=407273"},"modified":"2021-01-04T07:03:33","modified_gmt":"2021-01-04T12:03:33","slug":"freeline-to-participate-at-conferences-during-january-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/","title":{"rendered":"Freeline to participate at Conferences during January 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">LONDON, Jan.  04, 2021  (GLOBE NEWSWIRE) &#8212; Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the \u201cCompany\u201d or \u201cFreeline\u201d), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, today announced they will participate virtually at conferences during January 2021.<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>8 January 2021<\/strong> \u2013 Theresa Heggie, Chief Executive Officer, will join a panel \u2013 Broadening Gene Therapy \u2013 at the <strong>LifeSci Partners 10th Annual Healthcare Corporate Access Event <\/strong>from 10.00 am to 11.00 am ET, 3.00 pm to 4.00 pm GMT. A live audio webcast of the panel discussion will be available on the investor relations section of the Company\u2019s website at <a href=\"https:\/\/www.freeline.life\/investors-media\/newsroom\/?type=events\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Freeline<\/a>. <\/p>\n<\/li>\n<li style=\"text-align:justify\">\n          <strong>13 January 2021<\/strong> \u2013Theresa Heggie, Chief Executive Officer, will present at the <strong>39th Annual J.P. Morgan Healthcare Conference<\/strong> at 11.40 am ET, 4.40 pm GMT. The Company will host virtual one-on-one meetings at the J.P. Morgan event and a live audio webcast of the company presentation will be available on the investor relations section of the Company\u2019s website at <a href=\"https:\/\/www.freeline.life\/investors-media\/newsroom\/?type=events\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Freeline<\/a>. <\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About Freeline<\/strong><br \/>\n        <br \/>Freeline is a clinical-stage biotechnology company focused on AAV-based gene therapy targeting the liver. Its vision is to create better lives for people suffering from chronic, systemic diseases using the potential of gene therapy as a one-time treatment to provide a potential functional cure. Freeline is headquartered in the UK and has operations in Germany and the US.<\/p>\n<p>\n        <strong>Further information<\/strong>\n      <\/p>\n<p>\n        <strong>United States<\/strong>\n      <\/p>\n<p>David Arrington \u2013 Head of Investor Relations<br \/>+ 1 (646) 668 6947<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=udUzHFz54dRdE2hNRtMa03--AsnwC5vt0POEWKmQOdMpAl8yhXRphQFvvsUBhExObmSKqxlifS0ZhYea_bQu-jJik26uOLu3ZxFa9VLoEZ0-6QNv3DHXLmL9xZyN3YJs\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">david.arrington@freeline.life<\/a><\/p>\n<p>\n        <strong>LifeSci Advisors<\/strong><br \/>\n        <br \/>Dan Ferry<br \/>+1 (617) 430 7576<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4cskqX9wnnSjRAGvWrH9KNEoo8g-b230ih2_iEqcVRpL19jPil3GkaD4o_MMyHx7rNRtgtB5oV94ihA6Aw7xUp4MB6lWMJTGc47UW-DYVAdUceNW-WxB4Y32E4BYPJkh\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">daniel@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>Europe<\/strong><br \/>\n        <br \/>\n        <strong>JW Communications<\/strong><br \/>\n        <br \/>Julia Wilson<br \/>+44 (0) 7818 430877<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xo-8uIVOOUsVl66FMLmW3V68puEjEiqYSUOvrhdJWWTm1qNQMvVZH9jmUp694fdqzWbtSb4o9Q9n2a9dmbaCgidH6VPkIhonVEQEMOg0uG0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">juliawilsonuk@gmail.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTYyOSMzOTAyMTA0IzIyMDAzNjk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/f25a475c-bcd4-4907-946a-2ed4a2488b70\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LONDON, Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the \u201cCompany\u201d or \u201cFreeline\u201d), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, today announced they will participate virtually at conferences during January 2021. 8 January 2021 \u2013 Theresa Heggie, Chief Executive Officer, will join a panel \u2013 Broadening Gene Therapy \u2013 at the LifeSci Partners 10th Annual Healthcare Corporate Access Event from 10.00 am to 11.00 am ET, 3.00 pm to 4.00 pm GMT. A live audio webcast of the panel discussion will be available on the investor relations section of the Company\u2019s website at Freeline. 13 January 2021 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Freeline to participate at Conferences during January 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-407273","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Freeline to participate at Conferences during January 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Freeline to participate at Conferences during January 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LONDON, Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the \u201cCompany\u201d or \u201cFreeline\u201d), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, today announced they will participate virtually at conferences during January 2021. 8 January 2021 \u2013 Theresa Heggie, Chief Executive Officer, will join a panel \u2013 Broadening Gene Therapy \u2013 at the LifeSci Partners 10th Annual Healthcare Corporate Access Event from 10.00 am to 11.00 am ET, 3.00 pm to 4.00 pm GMT. A live audio webcast of the panel discussion will be available on the investor relations section of the Company\u2019s website at Freeline. 13 January 2021 &hellip; Continue reading &quot;Freeline to participate at Conferences during January 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-04T12:03:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTYyOSMzOTAyMTA0IzIyMDAzNjk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-at-conferences-during-january-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-at-conferences-during-january-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Freeline to participate at Conferences during January 2021\",\"datePublished\":\"2021-01-04T12:03:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-at-conferences-during-january-2021\\\/\"},\"wordCount\":261,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-at-conferences-during-january-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExOTYyOSMzOTAyMTA0IzIyMDAzNjk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-at-conferences-during-january-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-at-conferences-during-january-2021\\\/\",\"name\":\"Freeline to participate at Conferences during January 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-at-conferences-during-january-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-at-conferences-during-january-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExOTYyOSMzOTAyMTA0IzIyMDAzNjk=\",\"datePublished\":\"2021-01-04T12:03:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-at-conferences-during-january-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-at-conferences-during-january-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-at-conferences-during-january-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExOTYyOSMzOTAyMTA0IzIyMDAzNjk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExOTYyOSMzOTAyMTA0IzIyMDAzNjk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-to-participate-at-conferences-during-january-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Freeline to participate at Conferences during January 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Freeline to participate at Conferences during January 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/","og_locale":"en_US","og_type":"article","og_title":"Freeline to participate at Conferences during January 2021 - Market Newsdesk","og_description":"LONDON, Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the \u201cCompany\u201d or \u201cFreeline\u201d), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, today announced they will participate virtually at conferences during January 2021. 8 January 2021 \u2013 Theresa Heggie, Chief Executive Officer, will join a panel \u2013 Broadening Gene Therapy \u2013 at the LifeSci Partners 10th Annual Healthcare Corporate Access Event from 10.00 am to 11.00 am ET, 3.00 pm to 4.00 pm GMT. A live audio webcast of the panel discussion will be available on the investor relations section of the Company\u2019s website at Freeline. 13 January 2021 &hellip; Continue reading \"Freeline to participate at Conferences during January 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-04T12:03:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTYyOSMzOTAyMTA0IzIyMDAzNjk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Freeline to participate at Conferences during January 2021","datePublished":"2021-01-04T12:03:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/"},"wordCount":261,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTYyOSMzOTAyMTA0IzIyMDAzNjk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/","name":"Freeline to participate at Conferences during January 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTYyOSMzOTAyMTA0IzIyMDAzNjk=","datePublished":"2021-01-04T12:03:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTYyOSMzOTAyMTA0IzIyMDAzNjk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTYyOSMzOTAyMTA0IzIyMDAzNjk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-to-participate-at-conferences-during-january-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Freeline to participate at Conferences during January 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407273","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=407273"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407273\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=407273"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=407273"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=407273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}